IGF -I (CA) repeat polymorphisms and risk of cancer: A meta-analysis

Journal of Human Genetics

Volumn 53, Issue 3, 2008, Pages 227-238

  Chen, Xin ^a   Guan, Jianming ^b   Song, Yuting ^c   Chen, Peilin ^a   Zheng, Hongxia ^a   Tang, Cheng ^a   Wu, Qihan ^a  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b The Central Hospital of Minhang District   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Cancer; IGF I; Meta analysis; Polymorphism

Indexed keywords

SOMATOMEDIN C;

ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CLINICAL TRIAL; COLORECTAL CANCER; CONFIDENCE INTERVAL; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; META ANALYSIS; PROSTATE CANCER; SYSTEMATIC REVIEW; TANDEM REPEAT;

BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DNA; FEMALE; GENOTYPE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; NEOPLASMS; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 40049094965     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-007-0241-3     Document Type: Article

References (54)

1. Allen NE, Davey GK, Key TJ, Zhang S, Narod SA (2002) Serum insulin-like growth factor I (IGF-I) concentration in men is not associated with the cytosine-adenosine repeat polymorphism of the IGF-I gene. Cancer Epidemiol Biomarkers Prev 11:319-320
2. Cleveland RJ, Gammon MD, Edmiston SN, Teitelbaum SL, Britton JA, Terry MB, Eng SM, Neugut AI, Santella RM, Conway K (2006) IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. Carcinogenesis 27:758-765
3. Chen C, Freeman R, Voigt LF, Fitzpatrick A, Plymate SR, Weiss NS (2006) Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor. Cancer Epidemiol Biomarkers Prev 15(12):2461-2466
4. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279:563-566
5. DeLellis K, Ingles S, Kolonel L, McKean-Cowdin R, Henderson B, Stanczyk F, Probst-Hensch NM (2003) IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. Br J Cancer 88:277-282
6. Daughaday WH, Rotwein P (1989) Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10:68-91
7. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
8. Frayling TM, Hattersley AT, McCarthy A, Holly J, Mitchell SM, Gloyn AL, Owen K, Davies D, Smith GD Ben-Shlomo Y (2002) A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance and fetal growth in UK populations. Diabetes 51:2313-2316
9. Friedrichsen DM, Hawley S, Shu J, Humphrey M, Sabacan L, Iwasaki L, Etzioni R, Ostrander EA, Stanford JL (2005) IGF-I and IGFBP-3 polymorphisms and risk of prostate cancer. Prostate 65:44-51
10. Figer A, Karasik YP, Baruch RG, Chetrit A, Papa MZ, Sade RB, Rizel S, Friedman E (2002) Insulin-like growth factor I polymorphism and breast cancer risk in Jewish women. Isr Med Assoc J 4:759-762
11. González-Zuloeta Ladd AM, Liu F, Houben MP, Arias Vasquez A, Siemes C, Janssens AC, Coebergh JW, Hofman A, Janssen JA, Stricker BH, van Duijn CM. (2007) IGF-1 CA repeat variant and breast cancer risk in postmenopausal women. Eur J Cancer doi: 10.1016/j.ejca.2007.04.026
12. Gebhardt F, Zanker KS, Brandt B (1999) Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1. J Biol Chem 274:13176-13180
13. Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, Toivanen L, Koskenvuo M, Leinonen P, Koistinen R, Seppälä M (1996) Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 98:2612-2615
14. Hong Y, Pedersen NL, Brismar K, Hall K, de Faire U (1996) Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins. J Clin Endocrinol Metab 81:1791-1797
15. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-1396
16. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG (2001) Replication validity of genetic association studies. Nat Genet 29:306-309
17. Ioannidis JP, Rosenberg PS, Goedert JJ, O'Brien TR (2002) Commentary: metaanalysis of individual participants' data in genetic epidemiology. Am J Epidemiol 156:204-210
18. Jernstrom H, Chu W, Vesprini D, Vesprini D, Tao Y, Majeed N, Deal C, Pollak M, Narod SA (2001a) Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk. Mol Genet Metab 72:144-154
19. Jernstrom H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N, Hudson T, Narod SA, Pollak M (2001b) Genetic and non-genetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev 10:377-384
20. Kato I, Eastham J, Li B, Smith M, Yu H (2003) Genotype-phenotype analysis for the polymorphic CA repeat in the insulin-like growth factor-I (IGF-I) gene. Eur J Epidemiol 18(3):203-209
21. Li L, Cicek MS, Casey G, Witte JS (2004) No association between genetic polymorphisms in IGF-I and IGFBP-3 and prostate cancer. Cancer Epidemiol Biomarkers Prev 13:497-498
22. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127:820-826
23. Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics, 1999. CA Cancer J Clin 49:8-31, 1
24. LeRoith D, Raizada MK (ed) (1993) Proceedings of the 4th international symposium on insulin, IGFs, and their receptors, vol 343. Adv Exp Med Biol, 20-23 April 1993 Woods Hole, Massachusetts, pp 1-417
25. Morimoto LM, Newcomb PA, White E, Bigler J, Potter JD (2005) Insulin-like growth factor polymorphisms and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 14(5):1204-1211
26. Ma J, Pollak MN, Giovannucci E et al (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91:620-625
27. Missmer SA, Haiman CA, Hunter DJ, Willett WC, Colditz GA, Speizer FE, Pollak MN, Hankinson SE (2002) A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. Int J Cancer 100:332-336
28. Nam RK, Zhang WW, Trachtenberg J, Jewett MA, Emami M, Vesprini D, Chu W, Ho M, Sweet J, Evans A, Toi A, Pollak M, Narod SA (2003) Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer. Cancer Epidemiol Biomarkers Prev 12:1429-1437
29. Neuhausen SL, Slattery ML, Garner CP et al. (2005) Prostate cancer risk and IRS1, IRS2, IGF1, and INS polymorphisms: strong association of IRS1 G972R variant and cancer risk. Prostate 64:168-174
30. Pollak M (2000a) Insulin-like growth factor physiology and neoplasia. Growth Horm IGF Res 10:S6-S7
31. Pollak M (2000b) Insulin-like growth factor physiology and cancer risk. Eur J Cancer 36:1224-1228
32. Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37(Suppl 8):S4-S66
33. Parrizas M, LeRoith D (1997) Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product. Endocrinology 138:1355-1358
34. Petitti D (1994) Meta-analysis, decision analysis, and cost effectiveness analysis. Oxford University Press, New York
35. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds) (2002) Cancer incidence in five continents, vol VIII. IARC Sci Publ 155:1-781
36. Rietveld I, Janssen JA, Hofman A, Pols HA, van Duijn CM, Lamberts SW (2003) A polymorphism in the IGF-I gene influences the age-related decline in circulating total IGF-I levels. Eur J Endocrinol 148:171-175
37. Rosen CJ, Kurland ES, Vereault D, Adler RA, Rackoff PJ, Craig WY, Witte S, Rogers J, Bilezikian JP (1998) Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J Clin Endocrinol Metab 83:2286-2290
38. Rotwein P, Pollock KM, Didier DK, Krivi GG (1986) Organization and sequence of the human insulin-like growth factor I gene.Alternative RNA processing produces two insulin-like growth factor I precursor peptides. J Biol Chem 261:4828-4832
39. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346-1353
40. Schildkraut JM, Demark-Wahnefried W, Wenham RM, Grubber J, Jeffreys AS, Grambow SC, Marks JR, Moorman PG, Hoyo C, Ali S, Walther PJ (2005) IGF1 (CA)19 repeat and IGFBP3-202 A/C genotypes and the risk of prostate cancer in black and white men. Cancer Epidemiol Biomarkers Prev 14:403-408
41. Schaffer A, Koushik A, Trottier H, Duarte-Franco E, Mansour N, Arseneau J, Provencher D, Gilbert L, Gotlieb W, Ferenczy A, Coutlée F, Pollak MN, Franco EL; Biomarkers of cervical cancer risk study team (2007) Insulin-like growth factor-i and risk of high-grade cervical intraepithelial. Cancer Epidemiol Biomarkers Prev 16(4):716-722
42. Slattery ML, Murtaugh M, Caan B, Ma KN, Neuhausen S, Samowitz W (2005) Energy balance, insulin-related genes and risk of colon and rectal cancer. Int J Cancer: 115:148-154
43. Slattery ML, Samowitz W, Curtin K, Ma KN, Hoffman M, Caan B, Neuhausen S (2004) Associations among IRS1, IRS2, IGF1, and IGFBP-3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev 13(7):1206-1214
44. Tae HJ, Luo X, Kim KH (1994) Roles of CCAAT/enhancer-binding protein and its binding site on repression and derepression of acetyl-CoA carboxylase gene. J Biol Chem 269:10475-10484
45. Tsuchiya N, Wang L, Horikawa Y, Inouse T, Kakinuma H, Matsuura S, Sato K, Ogawa O, Kato T, Habuchi T (2005) CA repeat polymorphism in the insulin-like growth factor-I gene is associated with increased risk of prostate cancer and benign prostatic hyperplasia. Int J Oncol 26:225-231
46. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, Lamberts SW, Oostra BA, Pols HA, van Duijn CM (2001) A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50:637-642
47. Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253
48. Wen W, Gao YT, Shu XO, Yu H, Cai Q, Smith JR, Zheng W (2005) Insulinlike growth factor-I gene polymorphism and breast cancer risk in Chinese women. Int J Cancer 113:307-311
49. Wong H-L, DeLellis K, Nicole P-H, Woon-Puay K, David Van Den B, Hin-Peng L, Mimi CY, Sue AI (2005) A new single nucleotide polymorphism in the insulin-like growth factor i regulatory region associates with colorectal cancer risk in Singapore Chinese. Cancer Epidemiol Biomarkers Prev 14(1):144-150
50. Wagner K, Hemminki K, Israelsson E, Grzybowska E, Söderberg M, Pamula J, Pekala W, Zientek H, Mielzynska D, Siwinska E, Försti A (2005) Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer. Breast Cancer Res Treat 92:133-140
51. Weber JL, May PE (1989) Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 44:388-396
52. Yang RC, Roden RBS (2003) Genetic polymorphism and tumor immunotherapy. Curr Pharmacogenom 1:37-57
53. Yu H, Li BD, Smith M, Shi R, Berkel HJ, Kato I (2001) Polymorphic CA repeats in the IGF-I gene and breast cancer. Breast Cancer Res Treat 70:117-122
54. Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X (1999) Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst 91:151-156